Onderzoeker
Edward DE BROUWER
- Trefwoorden:Ongekend
- Disciplines:Immunologie niet elders geclassificeerd
Affiliaties
- Geneeskunde en Levenswetenschappen (Faculteit)
Lid
Vanaf16 okt 2021 → 31 dec 2023 - Biomedisch Onderzoeksinstituut (Onderzoeksinstituut)
Lid
Vanaf16 okt 2021 → 31 dec 2023 - Immunologie & Infectie (Departement)
Lid
Vanaf16 okt 2021 → 31 dec 2023 - Immunologie & Infectie (Onderzoeksgroep)
Lid
Vanaf16 okt 2021 → 31 dec 2023
Publicaties
1 - 9 van 9
- The Journey of Data Within a Global Data Sharing Initiative: A Federated 3-Layer Data Analysis Pipeline to Scale Up Multiple Sclerosis Research(2023)
Auteurs: Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Yves Moreau, Liesbet PEETERS
- Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta(2022)
Auteurs: Steve Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Liesbet PEETERS, Lotte GEYS, Tina PARCIAK, Anne Helme, Jan Hillert, Yves Moreau, Gilles Edan, et al.
- Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180](2022)
Auteurs: Edward DE BROUWER, Thijs BECKER, Yves Moreau, Eva Kubala Havrdova, Maria Trojano, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Pierre Grammond, Jens Kuhle, et al.
Pagina's: 106479 - Updated Results of the COVID-19 in MS Global Data Sharing Initiative(2022)
Auteurs: Steve Simpson-Yap, Ashkan PIRMANI, Tomas Kalincik, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, Anne Helme, Nick Rijke, Jan A. Hillert, Yves Moreau, et al.
Pagina's: e200021 - Associations of DMT therapies with COVID-19 severity in multiple sclerosis: an international cohort study(2022)
Auteurs: S. Simpson-Yap, Edward DE BROUWER, T. Kalincik, N. Rijke, J. Hillert, C. Walton, G. Edan, Y. Moreau, T. Spelman, Liesbet PEETERS
Pagina's: 4 - 913 - Introducing a prototype tool to speed-up data cleaning and enhancement for improving the use of real-world MS(2021)
Auteurs: Tina PARCIAK, L. Bekkers, Edward DE BROUWER, Frank NEVEN, Liesbet PEETERS
Pagina's: 696 - 696 - Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis(2021)
Auteurs: Steve Simpson-Yap, Edward DE BROUWER, Tomas Kalincik, Nick Rijke, Jan A. Hillert, Clare Walton, Gilles Edan, Yves Moreau, Tim Spelman, Lotte GEYS, et al.
Pagina's: E1870 - E1885 - Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression(2021)
Auteurs: Edward DE BROUWER, Thijs BECKER, Yves Moreau, Eva Havrdova, Maria Trojano, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Pierre Grammond, Jens Kuhle, et al.
- Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes(2021)
Auteurs: S. Simpson-Yap, Ashkan PIRMANI, Edward DE BROUWER, Lotte GEYS, Tina PARCIAK, A. Helme, N. Rijke, T. Kalincik, J. Hillert, Y. Moreau, et al.
Pagina's: 741 - 743